Famotidine vs ranitidine
Pro Research Analysisby 
Searched over 200M research papers
Efficacy of Famotidine vs Ranitidine in Duodenal and Gastric Ulcer Healing
Multiple studies have shown that famotidine and ranitidine are equally effective in healing both duodenal and gastric ulcers. In large, randomized, double-blind trials, healing rates for duodenal ulcers after 4 to 8 weeks of treatment were very similar between famotidine (at various dosing regimens) and ranitidine, with both drugs achieving healing rates above 87% at eight weeks. Both medications also provided similar pain relief and reduction in antacid use, and their safety profiles were comparable 14. For acute, benign gastric ulcers, healing rates at four, six, and eight weeks were nearly identical between famotidine and ranitidine, and both drugs were well tolerated .
Potency and Dosage Comparison: Famotidine vs Ranitidine
Famotidine is significantly more potent than ranitidine on a milligram-to-milligram basis. Animal studies and pharmacological reviews indicate that famotidine is about 7 to 9 times more potent than ranitidine in inhibiting gastric acid secretion, although both drugs have a similar duration of action 3579. This higher potency means that lower doses of famotidine can achieve the same antisecretory effects as higher doses of ranitidine .
Acid Suppression and Gastric pH Control
When comparing acid suppression, continuous intravenous infusion of ranitidine is more effective than intermittent bolus injections of famotidine in maintaining a gastric pH above 4 over a 24-hour period. After 12 hours, the pH with famotidine drops below optimal levels, suggesting that more frequent dosing or continuous infusion may be needed for prolonged acid suppression with famotidine . However, in clinical settings such as preoperative prophylaxis against acid aspiration, both single-dose oral famotidine and double-dose oral ranitidine are equally effective in increasing gastric pH and reducing gastric volume, with no significant differences between the two 810.
Safety and Tolerability of Famotidine and Ranitidine
Both famotidine and ranitidine are generally well tolerated, with similar rates of adverse effects reported in clinical trials. Famotidine, like ranitidine, does not have antiandrogenic effects or significantly inhibit hepatic drug metabolism, which are advantages over older H2-receptor antagonists like cimetidine .
Clinical Implications and Recommendations
For the treatment of duodenal and gastric ulcers, famotidine and ranitidine are equally effective and safe, with famotidine offering higher potency and similar duration of action. The choice between the two may depend on dosing convenience, cost, and specific clinical scenarios. For continuous acid suppression, ranitidine infusion may be superior, but for most clinical uses, either drug can be used effectively at recommended doses 1456+1 MORE.
Conclusion
Famotidine and ranitidine are both effective H2-receptor antagonists for the treatment of acid-peptic disorders, with similar efficacy, safety, and duration of action. Famotidine is more potent, allowing for lower dosing, but both drugs are interchangeable in most clinical situations. The choice should be guided by individual patient needs, dosing preferences, and clinical context.
Sources and full results
Most relevant research papers on this topic